Latest & greatest articles for adverse events

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adverse events or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on adverse events and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for adverse events

61. The prevalence of pain, analgesics use and their adverse events in patients with chronic kidney disease: protocol for a systematic review

The prevalence of pain, analgesics use and their adverse events in patients with chronic kidney disease: protocol for a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

62. Large-scale, national and institutional trends in adverse events over time: a systematic review of longitudinal retrospective patient record review studies

Large-scale, national and institutional trends in adverse events over time: a systematic review of longitudinal retrospective patient record review studies Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

63. Incidence of adverse events after peripheral administration of vasoactive agents: systematic review and meta-analysis

Incidence of adverse events after peripheral administration of vasoactive agents: systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

64. Outcomes and predictors of gastrointestinal immune-related adverse events (irAEs) due to immune checkpoint inhibitors: a systematic review and meta-analysis

Outcomes and predictors of gastrointestinal immune-related adverse events (irAEs) due to immune checkpoint inhibitors: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

65. Reporting of adverse events in clinical trials of therapeutic exercise in patients with hip osteoarthritis: a systematic review

Reporting of adverse events in clinical trials of therapeutic exercise in patients with hip osteoarthritis: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any

2019 PROSPERO

66. Post-progression survival and immune-related adverse events of immune-checkpoint inhibitors in multiple types of malignancies: a systematic review and network meta-analysis

Post-progression survival and immune-related adverse events of immune-checkpoint inhibitors in multiple types of malignancies: a systematic review and network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2019 PROSPERO

67. Pulmonary adverse events of small molecule tyrosine kinase inhibitors: meta-analysis and systematic review

Pulmonary adverse events of small molecule tyrosine kinase inhibitors: meta-analysis and systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files

2019 PROSPERO

68. Assessment of adverse events with immunotherapy in oncology: a systematic review and meta-analysis

Assessment of adverse events with immunotherapy in oncology: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

69. Cardiovascular adverse events in patients treated with denosumab for bone related outcomes

Cardiovascular adverse events in patients treated with denosumab for bone related outcomes Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

70. A meta-analysis: treatment-related adverse events of checkpoint inhibitors in clinical trials

A meta-analysis: treatment-related adverse events of checkpoint inhibitors in clinical trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

71. Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial. (Abstract)

Comparison of Major Adverse Cardiac Events Between Instantaneous Wave-Free Ratio and Fractional Flow Reserve-Guided Strategy in Patients With or Without Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial. Invasive physiologic indices such as fractional flow reserve (FFR) and instantaneous wave-free ratio (iFR) are used in clinical practice. Nevertheless, comparative prognostic outcomes of iFR-guided and FFR-guided treatment in patients with type 2 diabetes have not yet been (...) if they had intermediate coronary artery disease (40%-70% diameter stenosis) in at least 1 native coronary artery. Data were analyzed between January 2014 and December 2015.According to the study protocol, iFR of 0.89 or less and FFR of 0.80 or less were used as criteria for revascularization. When iFR or FFR was higher than the prespecified threshold, revascularization was deferred.The primary end point was major adverse cardiac events (MACE), defined as the composite of all-cause death, nonfatal

2019 JAMA cardiology Controlled trial quality: predicted high

72. Exercise training for protecting against major adverse health events in people with dementia: a systematic review and individual patient data meta-analysis

Exercise training for protecting against major adverse health events in people with dementia: a systematic review and individual patient data meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

73. Methodological quality of systematic review or meta-analysis on immune-related adverse events of immune checkpoint inhibitors in cancer patients

Methodological quality of systematic review or meta-analysis on immune-related adverse events of immune checkpoint inhibitors in cancer patients Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

74. The effect of computerized physician order entry on medication dosing errors and adverse drug events in pediatrics

The effect of computerized physician order entry on medication dosing errors and adverse drug events in pediatrics Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated

2019 PROSPERO

75. Serious adverse events associated with the use of lumbar spine manipulation or mobilization and patient characteristics: a systematic review

Serious adverse events associated with the use of lumbar spine manipulation or mobilization and patient characteristics: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2019 PROSPERO

76. Non-abuse adverse life events experienced by adults with eating disorders: a systematic review

Non-abuse adverse life events experienced by adults with eating disorders: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

77. Prescription of 5-fluorouracil/capecitabine versus S-1 and adverse drug events among colorectal cancer patients: a systematic review and meta-analysis

Prescription of 5-fluorouracil/capecitabine versus S-1 and adverse drug events among colorectal cancer patients: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

78. Is diarrhea an adverse event of the second generation of hormonal therapy in castration resistant prostate cancer? Data from a literature based meta-analysis

Is diarrhea an adverse event of the second generation of hormonal therapy in castration resistant prostate cancer? Data from a literature based meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2019 PROSPERO

79. Adverse events related to peripheral intravenous catheters: a systematic review

Adverse events related to peripheral intravenous catheters: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO

80. Adverse events following thoracic spinal thrust manipulation: a systematic review

Adverse events following thoracic spinal thrust manipulation: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email

2019 PROSPERO